Browsing: firstofits

On Thursday, July 16, 2026, the Food and Drug Administration (FDA) announced the approval of a new drug called Lipfendra (enlicitide) for the treatment of high cholesterol (hypercholesterolemia) and heterozygous familial hypercholesterolemia, an inherited form of high blood cholesterol